Please sign in to follow a disease.
Could a sprinkle of antibiotic powder in the ER prevent bone infections?
NCT ID NCT07659886
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial investigates whether applying vancomycin powder directly to open fracture wounds in the emergency department can reduce deep infections. Adults with open fractures are randomly assigned to receive either standard care or standard care plus a single dose of vancomycin powder in the wound before surgery. The main goal is to see if this simple addition lowers the rate of serious infections that require further treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- vancomycin powder
- What this could lead to
- If it works, this simple ER step could lower the risk of serious bone infections after open fractures, reducing the need for additional surgeries and antibiotics.
- What could go wrong
- This is a relatively small Phase 3 trial, so results may not apply to all fracture types or patients. Vancomycin allergy is a risk, and the powder might not prevent all infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants aged 18 years or older presenting to the Emergency Department with Gustilo-Anderson Type I, II, or III open fractures. Exclusion Criteria: * Known allergy to vancomycin * Ballistic open fractures * Pregnancy * Currently breastfeeding * Age younger than 18 years.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Open fracture are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Morristown Medical Center
Morristown, New Jersey, 07930, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 100,000-Patient global audit reveal how to make surgery safer?
- Can a light camera see bacteria on broken bones?
- Can wound bacteria predict infection after severe leg fractures?
- How much water to wash a broken bone? new study seeks answer.
- Can shorter antibiotic courses prevent infections in Kids' broken bones?